Michael D. Saunders

Michael Saunders practices at UW Medical Center - Montlake in Seattle, Washington, part of University of Washington.

Michael Saunders' NPI, 1891873253, was assigned on November 2, 2006. Michael Saunders graduated from Medical College of Wisconsin in 1993. Michael Saunders holds Washington license MD00033176.

Michael Saunders' primary practice is UW Medical Center - Montlake, at 1959 NE Pacific St Box 356151, Seattle, WA 98195 in King County. The practice phone is (206) 598-3300.

Michael Saunders' primary practice is UW Medical Center - Montlake in Seattle, Washington, part of University of Washington. Michael Saunders is also affiliated with Fred Hutchinson Cancer Center. The medical group on file is UW Physicians. Dmand AI also links Michael Saunders to 1 more hospital, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Saunders practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Michael Saunders' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Michael Saunders is licensed in Washington.

CMS data shows 335 Medicare services from Michael Saunders across 14 procedure codes in 2024, for 259 Medicare patients. Medicare paid $43,011 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 259 Medicare patients who saw Michael Saunders in 2024. The largest group is 65 to 74, with 138 patients. 64% of them have high blood pressure, and 58% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Saunders' median patient age at 63, with 51% women.

In 2024, Michael Saunders wrote 457 Medicare Part D claims for 168 patients. 78% of them were for generic drugs. CMS names the drug for 356 of them, across 13 drugs with 11 or more claims each, at $191,900 in total drug cost. In 2023, CMS named 323 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Michael Saunders for performance year 2024, reported through an alternative payment model (APM). Michael Saunders accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Michael Saunders as offering telehealth. CMS counts 302 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Michael Saunders, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 10 papers to Michael Saunders, published from 2011 to 2018. 2014 was the busiest year, with 2. The most frequent topics are Barrett Esophagus. Michael Saunders has published most often in Ann N Y Acad Sci. Michael Saunders' most frequent co-authors are David Reed Flum, Brant Kurt Oelschlager and Aaron M. Cheng, MD.

Dmand AI links Michael Saunders to 3 clinical trials, 2 of them phase 2 studies. Conditions studied include Barrett Esophagus, Colitis, Ulcerative and Crohn Disease. University of Washington sponsors the most, 2.

CMS Open Payments shows 68 general payments to Michael Saunders from 7 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 84% of the total. Covidien LP paid the most, $21,672.

Michael Saunders graduated from Medical College of Wisconsin in 1993.